Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Por um escritor misterioso
Last updated 11 novembro 2024
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Structural overlays help to rationalize the SAR for 18 , 19 and 23
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. - Abstract - Europe PMC
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Resolution achieved by automated reprocessing of data vs the resolution
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Prioritization of Molecular Targets for Antimalarial Drug Discovery
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Contacts between SC-58272 and Nmt1p.a, Contact distances (Å). The
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Discovery of a Novel Class of Orally Active Trypanocidal N- Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Plasmodium falciparum NMT substrates are involved in a variety of
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
PDF) Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Structure-guided design: (a) overlay of 3-OMe phenyl in 19 (PDB code
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Cryptosporidiosis Drug Discovery: Opportunities and Challenges
Identification of and Structural Insights into Hit Compounds Targeting  N-Myristoyltransferase for Cryptosporidium Drug Development
Frontiers Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for Cryptosporidium

© 2014-2024 progresstn.com. All rights reserved.